ORCID Profile
0000-0001-5694-4500
Current Organisation
Deakin University
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: MDPI AG
Date: 16-02-2022
Abstract: Ocular allergy is an immunoglobulin E-mediated Type I hypersensitivity reaction localised to the ocular surface and surrounding tissues. Primary signs and symptoms of ocular allergy include itching, redness, irritation and inflammation. Eye-rubbing caused by itching has been shown to alter ocular surface protein concentrations in conditions linked to ocular allergy such as keratoconus. In keratoconus, the cornea begins to thin and sag over time, leading to progressive vision loss and blindness in severe conditions. Due to the high incidence of ocular allergy sufferers rubbing their eyes in response to symptoms of itching, the protein landscape of the ocular surface may be significantly altered. Differential protein expression caused by long-term inflammation and eye-rubbing may lead to subsequent changes in ocular surface structure and function over time. This review aims to summarise and explore the findings of current ocular allergy proteome research conducted using techniques such as gel electrophoresis, mass spectrometry and lab-on-a-chip proteomics. Proteins of interest for this review include differentially expressed immunoglobulins, mucins, functional proteins, enzymes and proteins with previously uncharacterised roles in ocular allergy. Additionally, potential applications of this research are addressed in terms of diagnostics, drug development and future research prospects.
Publisher: Association for Research in Vision and Ophthalmology (ARVO)
Date: 27-05-2014
Abstract: To introduce a perimetric algorithm (gradient-oriented automated natural neighbor approach [GOANNA]) that automatically chooses spatial test locations to improve characterization of visual field (VF) loss without increasing test times. Computer simulations were undertaken to assess the performance of GOANNA. GOANNA was run on a 3° grid of 150 locations, and was compared with a zippy estimation by sequential testing (ZEST) thresholding strategy for locations in the 24-2 test pattern, with the remaining 98 locations being interpolated. Simulations were seeded using empirical data from 23 eyes with glaucoma that were measured at all 150 locations. The performance of the procedures was assessed by comparing the output thresholds to the input thresholds (accuracy and precision) and by evaluating the number of presentations required for the procedure to terminate (efficiency). When collated across whole-fields, there was no significant difference in accuracy, precision, or efficiency between GOANNA and ZEST. However, GOANNA targeted presentations on scotoma borders hence it was more precise and accurate at locations where the sensitivity gradient within the VF was high. Compared with ZEST, GOANNA was marginally less precise in areas of the VF that had spatially uniform sensitivity, but improved accuracy and precision in regions surrounding scotoma edges. GOANNA provides a principled framework for automatic placement of additional test locations to provide spatially denser testing around the borders of VF loss.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 25-09-2019
Publisher: Association for Research in Vision and Ophthalmology (ARVO)
Date: 05-2019
Abstract: To characterize visual loss across the full visual field in idiopathic intracranial hypertension (IIH) patients with mild central visual loss. We tested the full visual field (50° nasal, 80° temporal, 30° superior, 45° inferior) of 1 eye of 39 IIH patients by using static perimetry (size V) with the Open Perimetry Interface. Participants met the Dandy criteria for IIH and had at least Frisén grade 1 papilledema with better than -5 dB mean deviation (MD) centrally. Two observers (MW and AS) evaluated the visual field defects, adjudicated any differences, and reviewed optical coherence tomography data. We found a greater MD loss peripherally than centrally (central 26°). The median MD (and corresponding median absolute deviations) was -1.37 dB (1.61 dB) for the periphery and -0.77 dB (0.87 dB) for the central 26°, P < 0.001. There were about 30% more abnormal test locations identified in the periphery (P = 0.12), and the mean defect depth increased with eccentricity (P < 0.001). The most frequent defect found was a temporal wedge (23% of cases) in the periphery with another 23% that included this sector with inferior temporal loss. Although the presence of papilledema limited correlation, 55% of the temporal wedge defects had optical coherence tomography retinal nerve fiber layer deficits in the corresponding superonasal location. Other common visual field defects were inferonasal loss, superonasal loss, and superior and inferior arcuate defects. Seven patients (18%) had visual field defects in the periphery with normal central visual field testing. In IIH patients, we found substantial visual loss both outside 30° of the visual field and inside 30° with the depth of the defect increasing linearly with eccentricity. Temporal wedge defects were the most common visual field defect in the periphery. Static threshold perimetry of the full visual field appears to be clinically useful in IIH patients.
Publisher: Elsevier BV
Date: 12-2018
Publisher: Elsevier BV
Date: 02-2019
DOI: 10.1016/J.AJO.2018.10.010
Abstract: To describe a new time-saving threshold visual field-testing strategy-Swedish Interactive Thresholding Algorithm (SITA) Faster, which is intended to replace SITA Fast-and to report on a clinical evaluation of this new strategy. Description and validity analysis for modifications applied to SITA Fast. Five centers tested 1 eye of each of 126 glaucoma and glaucoma suspect patients with SITA Faster, SITA Fast, and SITA Standard at each of 2 visits. Outcomes included test time, mean deviation, and the visual field index (VFI), significant test points in probability maps, and intertest threshold variability. Mean (standard deviation) test times were 171.9 (45.3) seconds for SITA Faster, 247.0 (56.7) for SITA Fast, and 369.5 (64.5) for SITA Standard (P < .001). SITA Faster test times averaged 30.4 % shorter than SITA Fast and 53.5 % shorter than SITA Standard. Mean deviation was similar among all 3 tests.VFI did not differ between SITA Fast and SITA Faster tests, mean difference 0%, but VFI values were 1.2% lower with SITA Standard compared to both SITA Fast (P = .007) and SITA Faster (P = .002). A similar trend was seen with a slightly higher number of significant test points with SITA Standard than with SITA Fast and SITA Faster. All 3 tests had similar test-retest variability over the entire range of threshold values. SITA Faster saved considerable test time. SITA Faster and SITA Fast gave almost identical results. There were small differences between SITA Faster and SITA Standard, of the same character as previously shown for SITA Fast vs SITA Standard.
Publisher: Wiley
Date: 13-02-2015
DOI: 10.1111/OPO.12184
Abstract: A new automated visual field testing approach that s les scotoma edges at a finer spatial resolution, GOANNA (Gradient-Oriented Automated Natural Neighbour Approach) was previously shown to improve accuracy and precision around those regions compared to current procedures in computer simulation. The purpose of this study was to observe if this improvement translated to more accurate classification of glaucomatous progression. Computer simulations were undertaken on six procedures: three variants of GOANNA on 150 locations two variants of ZEST on 52 locations and the ideal case where true thresholds are perfectly measured. The median number of presentations of GOANNA was matched to ZEST. The procedures were run on 156 sequences of simulated progressing fields and 156 sequences of stable fields to determine sensitivity and specificity using point-wise linear regression. Reliable (0% FP, 0% FN) and typical false positive (15% FP, 3% FN) response error conditions were investigated. Area under ROC curves (AUC) were plotted against the number of visual fields acquired to evaluate the performance of these procedures. The GOANNA framework exhibited equal or greater AUC than ZEST at all visits when baseline fields were initially defective (under both response error conditions) and when baseline fields were initially healthy when no false responses were made. Retest implementations of GOANNA exhibited an improvement over the original GOANNA after the first seven visits when fields were initially healthy. The results suggest that the improvement in precision and accuracy around scotoma borders seen in the GOANNA framework translates to earlier and more accurate detection of progressing fields compared with ZEST, especially in the early stages of glaucomatous progression.
Publisher: Ovid Technologies (Wolters Kluwer Health)
Date: 07-01-2020
Publisher: Association for Research in Vision and Ophthalmology (ARVO)
Date: 09-2016
DOI: 10.1167/TVST.5.5.1
Location: United States of America
No related grants have been discovered for Luke Chong.